Načítá se...
Developments in Glycopeptide Antibiotics
[Image: see text] Glycopeptide antibiotics (GPAs) are a key weapon in the fight against drug resistant bacteria, with vancomycin still a mainstream therapy against serious Gram-positive infections more than 50 years after it was first introduced. New, more potent semisynthetic derivatives that have...
Uloženo v:
| Vydáno v: | ACS Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical
Society
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952257/ https://ncbi.nlm.nih.gov/pubmed/29363950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.7b00258 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|